Anna Gloyn - Professor of Pediatrics (Endocrinology) and (by courtesy) of Genetics
Bio-X Affiliated Faculty
The consistent focus of Dr. Anna Gloyn's research has been using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology. Her early post-doctoral research led to the identification a new genetic aetiology for permanent and transient neonatal diabetes due to KCNJ11 mutations and resulted in one of the first examples of precision medicine, where the determination of the molecular genetic aetiology lead to improved treatment options for patients. Whilst she was in Oxford, Dr.
